Lilly's Migraine drug receives FDA approval

Drug Discovery |  News | 0 Comment | 14 Oct, 2019

Eli Lilly and Company  has announced that the U.S. Food and Drug Administration (FDA) has approved REYVOW™ (lasmiditan) an oral medication for the acute treatment of mi...Read more

Gilead Sciences submits NDA to treat RA in Japan

Drug Discovery |  News | 0 Comment | 09 Oct, 2019

Gilead Sciences, Inc. has announced the New Drug Application (NDA) for filgotinib, an investigational, oral, selective JAK1 inhibitor for the treatment of adults with rheumatoid arthri...Read more

Bayer and RIKEN establish partnership for novel drug discovery

Drug Discovery |  News | 0 Comment | 09 Oct, 2019

Bayer AG (Bayer), and RIKEN Innovation Co., Ltd. (RIKEN Innovation), have entered into a strategic collaboration agreement to jointly explore novel drug discovery opportunities across indic...Read more

Novo Nordisk set to bring innovative treatment for type 2 diabetes

Drug Discovery |  News | 0 Comment | 23 Sep, 2019

Novo Nordisk announced that the U.S. Food and Drug Administration (FDA) has approved Rybelsus® (semaglutide) tablets 7 mg or 14 mg for adults with type 2 diabetes that along with d...Read more

FDA approves combo drug to treat endometrial carcinoma

Drug Discovery |  News | 0 Comment | 19 Sep, 2019

Eisai and Merck have announced that the U.S. Food and Drug Administration (FDA) approved the combination of LENVIMA, the orally available kinase inhibitor discovered by Eisai, plus KEYTRUDA...Read more

FDA Grants Breakthrough Therapy Designation for Genentech’s Gazyva (Obinutuzumab)

Drug Discovery |  News | 0 Comment | 18 Sep, 2019

Genentech, a member of the Roche Group has announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation (BTD) to Gazyva® (obinutuzumab) f...Read more

FDA grants priority review for Merck’s Ebola Vaccine

Drug Discovery |  Influencers | 0 Comment | 17 Sep, 2019

Merck, known as MSD outside the United States and Canada, has announced that the U.S. Food and Drug Administration (FDA) has accepted the Biologics License Application (BLA) and granted pri...Read more

Certara launches V8.2 of Phoenix PK/PD modeling & simulation software for drugs

Drug Discovery |  News | 0 Comment | 15 Sep, 2019

Certara®, the global model-informed drug development and decision support leader, on 12 Sep 2019, announced the launch of Phoenix® 8.2, the industry gold standard in pharmacoki...Read more

Chugai Presents Results from Second Positive Global Phase III Clinical Study of Satralizumab

Drug Discovery |  News | 0 Comment | 12 Sep, 2019

Chugai Pharmaceutical Co., Ltd. (TOKYO:4519) announced that the results from SAkuraStar Study were presented at the Congress of European Committee for Treatment and Research in Multipl...Read more

Hansoh Pharma, Atomwise partner for AI Drug Discovery

Drug Discovery |  News | 0 Comment | 12 Sep, 2019

Hansoh Pharmaceutical Group Company Limited (“Hansoh Pharma”), a leading biopharmaceutical company in China, and Atomwise, Inc. (“Atomwise”), the leader in artificia...Read more

Daiichi Sankyo Advances [Fam-] Trastuzumab in Japan

Drug Discovery |  News | 0 Comment | 10 Sep, 2019

 Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) has announced the submission of a New Drug Application (NDA) to Japan’s Ministry of Health, Labour and Welfare (MHLW)...Read more

Invicro Appoints Hidenori Seshimo as Vice President of Biomarker Services, Japan

Drug Discovery |  News | 0 Comment | 30 Aug, 2019

Invicro , a member of the Konica Minolta Group and a leading provider of biomarkers for imaging, core lab services and software for research and development of drugs, announced today the ap...Read more

THC Global Groups' Australalia's Facility Opened by Federal Minister for Health

Drug Discovery |  News | 0 Comment | 22 Aug, 2019

THC Global Group Limited (THC Global or the Company) has announced that its Southport Facility was opened by the Federal Minister for Health, The Honourable Greg Hunt MP. The Southport Fac...Read more

FDA fast tracks AstraZeneca's FARXIGA

Drug Discovery |  News | 0 Comment | 28 Aug, 2019

AstraZeneca has announced that the US Food and Drug Administration (FDA) has granted Fast Track designation for the development of FARXIGA (dapagliflozin) to delay the progression of renal ...Read more

Japan's BioWa extends partnership with Cantargia

Drug Discovery |  News | 0 Comment | 27 Aug, 2019

Cantargia AB and BioWa Inc. have signed an extension of the license agreement around the BioWa proprietary POTELLIGENTTechnology for production of Cantargia’s antibody drug candidate ...Read more

Voronoi selects CDD Vault platform to manage Drug Discovery Data

Drug Discovery |  News | 0 Comment | 23 Aug, 2019

Voronoi, drug discovery and development biotech company in Korea has announced that it has, after an extensive evaluation process, selected CDD Vault as its platform of choice to manage its...Read more

Innovent to develop & commercialize a novel diabetes medicine in China

Drug Discovery |  News | 0 Comment | 22 Aug, 2019

Innovent Biologics, Inc., a world-class biopharmaceutical company that develops and commercializes high-quality medicines, has announced that it has entered into a licensing agreement with ...Read more

FDA approves new antibiotic to treat community-acquired bacterial pneumonia

Drug Discovery |  News | 0 Comment | 20 Aug, 2019

The U.S. Food and Drug Administration, on 19 August 2019, approved Xenleta (lefamulin) to treat adults with community-acquired bacterial pneumonia. “This new drug provides another op...Read more